From Molecular to Modular Tumor Therapy : Tumors are Reconstructible Communicatively Evolving Systems /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2010.
|
| Edición: | 1st ed. 2010. |
| Colección: | The Tumor Microenvironment ;
3 |
| Materias: |
Tabla de Contenidos:
- Therapy-Derived Systems Biology: A Pragmatic Communication Theory
- Bridging Theory and Therapeutic Practice: From Generalized Disease Models to Particular Patients
- Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options
- Principles of Modular Tumor Therapy
- Tumors Share Common Processes During Tumor Evolution: Communicative Aspects of a Situation’s Interpretation for Creating Systems-Directed Therapies
- Cancer and Coagulation; Focusing on Tissue Factor and Heparanase
- The Role of Mesenchymal Cells in Cancer: Contribution to Tumor Stroma and Tumorigenic Capacity
- Shaping Tumor Associated Macrophages: The Role of NF-?B
- The Metabolic Achilles Heel: Tumor Cell Metabolism as Therapeutic Target
- Could Be Systems-Directed Therapy Approaches Promising in Glioblastoma Patients?
- Systems-Relevant Molecular and Cellular Targets: Implementation of Modular ‘Knowledge’
- Functional Impacts of Signal Integration: Regulation of Inflammation-Related Transcription Factors by Heterotrimeric G Proteins
- Molecular Cross-Talk Between Nuclear Receptors and Nuclear Factor-?B
- The Biomodulatory Capacities of Low-Dose Metronomic Chemotherapy: Complex Modulation of the Tumor Microenvironment
- Tumors are Evolvable Modular and Rationalized Systems: From Molecular to Modular Tumor Therapy
- Systems Biology: A Therapeutic Target for Tumor Therapy
- The Comparative Uncovering of Tumor Systems Biology by Modularly Targeting Tumor-Associated Inflammation
- Searching for the ‘Metabolism’ of Evolution
- Biomodulatory Therapy Approaches in Metastatic Cancer
- The Impact of Inflammation Control and Active Cancer Palliation on Metabolic Pathways Determining Tumor Progression and Patient Survival
- Pioglitazone and Rofecoxib Combined with Angiostatically Scheduled Capecitabine in Far-Advanced Hepatobiliary Carcinoma
- C-Reactive Protein As a Secretome-Derived Biomarker for Predicting Response to Biomodulatory Therapy in Metastatic Renal Clear Cell Carcinoma
- Modular Therapy Approach in Metastatic Castration-Resistent Prostate Cancer
- Systems-Directed Therapy in Metastatic Castration-Resistent Prostate Cancer (CRCP)
- Criteria for Checking Systems Behavior and Creating Predictions: Systems-Associated Biomarkers and Molecular Imaging
- Early Detection of Systems Response: Molecular and Functional Imaging of Angiogenesis
- Secretome Proteomics, a Novel Tool for Biomarkers Discovery and for Guiding Biomodulatory Therapy Approaches
- Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
- Pharmacological Considerations on Systems Biological Therapy Approaches
- Uncovering Tumor Systems Biology by Biomodulatory Therapy Strategies
- Breathing New Life into Old Drugs: Indication Discovery by Systems Directed Therapy
- Tumors’ Systems Biology: Implications for Personalized Therapy
- A Methodological Approach to Personalized Therapies in Metastatic Cancer
- Summary
- To Be an Object in a Biological System
- From Molecular to Modular, from Theme-Dependent to Evolution-Adjusted Tumor Therapy.